|
|
Abstracts
Session: The State of Oyster Disease
Pathogens Research Findings
Presented By:
Public and regulatory concern for persistent illnesses due to consumption of raw oysters, particularly for consumers at-risk due to compromised health, has culminated federal mandates to advance use of post harvest treatments (PHT) that could reduce the risk. These mandates specify measures in terms of actual amounts of production to be processed by new PHT increasing annually through the next five years (2002-2006). Failure to comply could result in more stringent regulatory consequences. New and innovative PHT methods that will not impose significant costs and training requirements and lead to market success are critically needed by the oyster industry.
|